Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Narrative Review on Therapeutic Potential of Naringenin in Colorectal Cancer: Focusing on Molecular and Biochemical Processes Publisher Pubmed



Zamanian MY1, 2 ; Golmohammadi M3 ; Abdullaev B4, 5, 6 ; Garcia MO7 ; Alazbjee AAA8 ; Kumar A9 ; Mohaamed SS10 ; Hussien BM11, 12, 13 ; Khalaj F14 ; Hodaei SM15 ; Shirsalimi N1 ; Moriasi G16
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Physiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  2. 2. Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
  3. 3. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Central Asian Center of Development Studies, New Uzbekistan University, Tashkent, Uzbekistan
  5. 5. School of Medicine, Central Asian University, Tashkent, Uzbekistan
  6. 6. Department of Medical Oncology and Radiology, Samarkand State Medical University, Uzbekistan
  7. 7. Universidad Estatal de Bolivar, Facultad de Ciencias de la Salud y del Ser Humano, Carrera de Enfermeria, CP, Guaranda, Ecuador
  8. 8. Collage of Medicine, Al-Ayen University, Thi-Qar, Iraq
  9. 9. Department of Nuclear and Renewable Energy, Ural Federal University Named after the First President of Russia Boris Yeltsin, Ekaterinburg, Russian Federation
  10. 10. Department of Pharmacy, Al Rafidain University College, Bagdad, Iraq
  11. 11. Medical Laboratory Technique College, the Islamic University, Najaf, Iraq
  12. 12. Medical Laboratory Technique College, the Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq
  13. 13. Medical Laboratory Technique College, the Islamic University of Babylon, Babylon, Iraq
  14. 14. Digestive Diseases Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  15. 15. Student Research Committee, Arak University of Medical Sciences, Arak, Iran
  16. 16. Department of Medical Biochemistry, School of Medicine, College of Health Sciences, Mount Kenya University, Thika, Kenya

Source: Cell Biochemistry and Function Published:2024


Abstract

Colorectal cancer (CRC) is a common and highly metastatic cancer affecting people worldwide. Drug resistance and unwanted side effects are some of the limitations of current treatments for CRC. Naringenin (NAR) is a naturally occurring compound found in abundance in various citrus fruits such as oranges, grapefruits, and tomatoes. It possesses a diverse range of pharmacological and biological properties that are beneficial for human health. Numerous studies have highlighted its antioxidant, anticancer, and anti-inflammatory activities, making it a subject of interest in scientific research. This review provides a comprehensive overview of the effects of NAR on CRC. The study's findings indicated that NAR: (1) interacts with estrogen receptors, (2) regulates the expression of genes related to the p53 signaling pathway, (3) promotes apoptosis by increasing the expression of proapoptotic genes (Bax, caspase9, and p53) and downregulation of the antiapoptotic gene Bcl2, (4) inhibits the activity of enzymes involved in cell survival and proliferation, (5) decreases cyclin D1 levels, (6) reduces the expression of cyclin-dependent kinases (Cdk4, Cdk6, and Cdk7) and antiapoptotic genes (Bcl2, x-IAP, and c-IAP-2) in CRC cells. In vitro CDK2 binding assay was also performed, showing that the NAR derivatives had better inhibitory activities on CDK2 than NAR. Based on the findings of this study, NAR is a potential therapeutic agent for CRC. Additional pharmacology and pharmacokinetics studies are required to fully elucidate the mechanisms of action of NAR and establish the most suitable dose for subsequent clinical investigations. © 2024 John Wiley & Sons Ltd.
Other Related Docs
32. Comparison of Four Data Mining Algorithms for Predicting Colorectal Cancer Risk, Journal of Advances in Medical and Biomedical Research (2021)
35. Chemotherapy: A Double-Edged Sword in Cancer Treatment, Cancer Immunology# Immunotherapy (2022)
50. Anti-Cd20 Antibody Treatment for B-Cell Malignancies, Resistance to Anti-CD20 Antibodies and approaches for their Reversal: Volume 2 (2023)